Quantcast

Latest King Pharmaceuticals Stories

2014-08-04 16:26:29

NEWARK, Calif., Aug. 4, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced the appointment of R. Scott Shively, as Chief Commercial Officer and Senior Vice President. Mr. Shively has extensive commercial leadership experience in sales and marketing of pain and neurology products, for both specialty as well as larger pharmaceutical companies. Mr. Shively served as Executive Vice President and Chief Commercial Officer of Zogenix from November 2012 through August...

2014-06-11 08:32:20

If You Operate a Business in Tennessee and Indirectly Purchased Skelaxin for Resale Since November 4, 2005, You Could be Affected by a Proposed Class Action Settlement. KNOXVILLE, Tenn., June 11, 2014 /PRNewswire/ -- The following statement is being issued by the Law Offices of Gordon Ball and Hausfeld LLP regarding the Skelaxin Proposed Class Action Settlement. What is this about? Subject to Court Approval, a Settlement has been reached in a class action lawsuit claiming that King...

2014-06-04 08:29:53

PITTSBURGH, June 4, 2014 /PRNewswire/ -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today the appointment of Richard W. Pascoe as a member of the Company's Board of Directors. Mr. Pascoe is currently the Chief Executive Officer of Apricus Biosciences, Inc., a pharmaceutical company focused on the development and commercialization of novel therapeutics for men's and women's health. Mr. Pascoe joined Apricus in...

2014-01-13 12:26:59

Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel for Stine Seed Company, Added to KemPharm's Board CORALVILLE, Iowa, Jan. 13, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today the appointment of Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel, Stine Seed...

2013-12-05 23:04:28

Reportbuyer.com just published a new market research report: Drug Delivery Partnering Terms and Agreements. London (PRWEB) December 05, 2013 The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals....

2013-10-09 23:23:02

Reportbuyer.com just published a new market research report: Drug Delivery Partnering Terms and Agreements. London (PRWEB) October 09, 2013 The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The...

2013-07-01 23:18:54

Michael Valentino the former President and CEO of Xanodyne Pharmaceuticals, Inc. brings extensive track record and insight market results to UrgentRx. Denver, CO (PRWEB) July 01, 2013 UrgentRx, developer of fast acting over-the-counter flavored powder medications, today announced Michael Valentino will join the company's Board of Directors. Valentino brings more than 30 years of leadership experience at both major pharmaceutical companies and venture-backed start-ups. His most recent...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related